Because of these characteristics, CD133(+) MIC [34] and other cancer stem cells [35] have been proposed to play a critical role in recurrence and reduced survival, and are of interest as an anti-cancer vaccination component, with some success in mouse models of melanoma [36]. Here, PROM1 is linked to cancer.